Literature DB >> 7644664

Newer antifolates in cancer therapy.

R M Schultz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7644664     DOI： 10.1007/978-3-0348-7161-7_4

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN： 0071-786X


× No keyword cloud information.
  2 in total

1.  Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.

Authors:  V J Chen; J R Bewley; S L Andis; R M Schultz; P W Iversen; C Shih; L G Mendelsohn; D E Seitz; J L Tonkinson
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

2.  Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.

Authors:  J Yan; N Zhong; G Liu; K Chen; X Liu; L Su; S Singhal
Journal:  Cell Death Dis       Date:  2014-07-03       Impact factor: 8.469
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.